Cancer Genomic Testing Market Market Overview
Cancer Genomic Testing Market was valued at USD 10.5 Billion in 2022 and is projected to reach USD 22.3 Billion by 2030, growing at a CAGR of 10.2% from 2024 to 2030.
Market Size and Opportunity Analysis for Global Cancer Genomic Testing Market
The global cancer genomic testing market is projected to reach approximately USD 10 billion by 2025, growing at a compound annual growth rate (CAGR) of around 12% from 2020. This significant market value reflects the increasing demand for personalized medicine and advancements in genomic technologies. The growing prevalence of cancer worldwide, along with rising awareness about early detection and targeted therapies, drives the market’s expansion. Additionally, the integration of genomic testing in routine cancer care and research further fuels growth, presenting ample opportunities for industry stakeholders.
With the continuous evolution in genomic sequencing technologies and a robust pipeline of innovative cancer therapies, the market is expected to see substantial growth. Key players in the industry are investing in research and development to enhance testing accuracy and expand the range of detectable genetic mutations. The ultimate opportunity lies in leveraging these advancements to meet the rising demand for personalized cancer treatment solutions. As the field progresses, strategic collaborations and investments will likely be crucial in capturing a significant share of this burgeoning market.
Get an In-Depth Research Analysis of the Global Cancer Genomic Testing Market Size And Forecast [2024-2031]
Who are the largest Global manufacturers in the Cancer Genomic Testing Market?
By Test Type
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescent In Situ Hybridization (FISH)
- Microarray Analysis
- Other Genomic Testing Methods
By Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
- Other Cancers
By Method of Sample Collection
- Tissue Biopsies
- Blood Sample-Based Testing
- Urine-Based Tests
- Saliva Tests
By End User
- Hospitals
- Diagnostic Laboratories
- Research Institutions
- Pharmaceutical Companies
By Application
- Risk Assessment
- Patient Stratification
- Therapeutic Decision Making
- Monitoring Treatment Response
- Recurrence and Progression Monitoring
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Cancer Genomic Testing Market Size And Forecast [2024-2031]
Segmentation of Cancer Genomic Testing Market-
Which regions are leading the Global Cancer Genomic Testing Market?
- Global (United States, Global and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil, Argentina, Columbia, etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Cancer Genomic Testing Market Research Analysis
Detailed TOC of Global Cancer Genomic Testing Market Research Report, 2024-2031
1. Introduction of the Global Cancer Genomic Testing Market
- Overview of the Market
- Scope of Report
- Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Research
- Data Mining
- Validation
- Primary Interviews
- List of Data Sources
4. Global Cancer Genomic Testing Market Outlook
- Overview
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porters Five Force Model
- Value Chain Analysis
5. Global Cancer Genomic Testing Market, By Type
6. Global Cancer Genomic Testing Market, By Application
7. Global Cancer Genomic Testing Market, By Geography
- Global
- Europe
- Asia Pacific
- Rest of the World
8. Global Cancer Genomic Testing Market Competitive Landscape
- Overview
- Company Market Ranking
- Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768